Are There Shortages and Regional Disparities in Lecanemab Treatment Facilities? A Cross-Sectional Study

• Main Authors: Kazuki Ohashi (Author), Ikuko Takahashi-Iwata (Author), Zhao Jieyu (Author), Ken Sakushima (Author), Ichiro Yabe (Author), Katsuhiko Ogasawara (Author)
• Format: Book
• Published: SAGE Publishing, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Alzheimer disease (AD) is the most common type of dementia, affecting 70% of patients with dementia. In Japan, over 5 million people aged 65 years and older had dementia in 2018, and this figure is expected to rise to 25% to 30% of this age group by 2045. In Japan, lecanemab, which was...